PRAME and cancer: A mixture of three mRNAs encoding constitutively activatedCLT4, CD40L, and TLR4 plus mRNAs for five melanoma-associated antigens(tyrosinase, gp100, MAGE-A3, MAGE-C2, and PRAME), which activate key immune cellsagainst cancer